ENTX: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation — AI Analysis

⌘K

Full Access with Signal8 Pro, $49/mo billed annually.

This press release is temporarily unavailable.

Please refresh in a moment.

ENTX: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation — AI Analysis | Signal8